Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
On-chain liquidity distribution protocol Turtle completes $5.5 million financing, with participation from GSR, FalconX, and others

On-chain liquidity distribution protocol Turtle completes $5.5 million financing, with participation from GSR, FalconX, and others

ChaincatcherChaincatcher2025/10/20 13:59
Show original

ChainCatcher reported that the on-chain liquidity distribution protocol Turtle has completed a new funding round of $5.5 million, bringing its total funding to $11.7 million. This round received support from several institutions, including follow-on investors such as Bitscale VC, Theia, and Trident Digital, as well as new investors such as SNZ HOLDING, GSR, FalconX, and Anchorage VC.

Turtle CEO Essi Lagevardi stated: "Liquidity is the infrastructure on which everything operates. We are making liquidity programmable—transparent, efficient, and coordinated."

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A key leap toward the internationalization of the Korean won: The Bank of Korea launches a trial run of its 24/7 international settlement system, with full deployment set for January next year.

The Bank of Korea officially launched the trial operation of the "BOK Won International Payment Network" on Monday local time.

智通财经2026/09/21 07:31

Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD

Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.

智通财经2026/09/21 07:16

Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.

U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).

智通财经2026/09/21 07:11